Xencor, Inc. (XNCR)
29.21
-0.78
(-2.60%)
USD |
NASDAQ |
Oct 29, 16:00
28.87
-0.34
(-1.16%)
After-Hours: 06:08
Xencor Enterprise Value : 1.885B for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 1.885B |
| October 28, 2026 | 1.943B |
| October 27, 2026 | 1.943B |
| October 26, 2026 | 1.883B |
| October 23, 2026 | 1.585B |
| October 22, 2026 | 1.634B |
| October 21, 2026 | 1.584B |
| October 20, 2026 | 1.567B |
| October 19, 2026 | 1.437B |
| October 16, 2026 | 1.412B |
| October 15, 2026 | 1.498B |
| October 14, 2026 | 1.452B |
| October 13, 2026 | 1.462B |
| October 12, 2026 | 1.575B |
| October 09, 2026 | 1.544B |
| October 08, 2026 | 1.535B |
| October 07, 2026 | 1.517B |
| October 06, 2026 | 1.524B |
| October 05, 2026 | 1.619B |
| October 02, 2026 | 1.560B |
| October 01, 2026 | 1.555B |
| September 30, 2026 | 1.568B |
| September 29, 2026 | 1.572B |
| September 28, 2026 | 1.616B |
| September 25, 2026 | 1.483B |
| Date | Value |
|---|---|
| September 24, 2026 | 1.489B |
| September 23, 2026 | 1.517B |
| September 22, 2026 | 1.584B |
| September 21, 2026 | 1.574B |
| September 18, 2026 | 1.551B |
| September 17, 2026 | 1.541B |
| September 16, 2026 | 1.476B |
| September 15, 2026 | 1.479B |
| September 14, 2026 | 1.537B |
| September 11, 2026 | 1.528B |
| September 10, 2026 | 1.517B |
| September 09, 2026 | 1.567B |
| September 08, 2026 | 1.596B |
| September 04, 2026 | 1.692B |
| September 03, 2026 | 1.692B |
| September 02, 2026 | 1.713B |
| September 01, 2026 | 1.788B |
| August 31, 2026 | 1.740B |
| August 28, 2026 | 1.651B |
| August 27, 2026 | 1.860B |
| August 26, 2026 | 1.828B |
| August 25, 2026 | 1.891B |
| August 24, 2026 | 1.869B |
| August 21, 2026 | 1.780B |
| August 20, 2026 | 1.721B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ironwood Pharmaceuticals, Inc. | 915.91M |
| UroGen Pharma Ltd. | 1.723B |
| MeiraGTx Holdings Plc | 883.46M |
| IDEAYA Biosciences, Inc. | 2.370B |
| Iovance Biotherapeutics, Inc. | 4.079B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.73M |
| Revenue (Quarterly) | 51.22M |
| Total Expenses (Quarterly) | 72.95M |
| EPS Diluted (Quarterly) | -0.2864 |
| Gross Profit Margin (Quarterly) | 95.24% |
| Profit Margin (Quarterly) | -42.42% |
| Earnings Yield | -7.43% |
| Normalized Earnings Yield | -9.014 |